Leading Epidemiologist Marianne Cunnington Joins Analysis Group from the Pharmaceutical Industry

August 18, 2022

Analysis Group is pleased to welcome Dr. Marianne Cunnington to its London office as a Vice President. Dr. Cunnington has two decades of experience as a pharmaceutical industry epidemiologist, specializing in the generation of real-world evidence (RWE) in support of the development of pharmaceutical and vaccine products, regulatory risk management strategies, and product risk-benefit assessments. Her experience with regulatory agencies in the US, the UK, Europe, and Asia includes new product registration submissions, post-approval safety studies, and post-marketing requirements and commitments. She has presented at over 40 international conferences, and her research has been published in many peer-reviewed journals. Prior to joining Analysis Group, Dr. Cunnington was accountable for regulatory real-world safety studies at GSK. She also has extensive experience leading industry epidemiology functions. Dr. Cunnington holds a Ph.D. in infectious disease epidemiology from the London School of Hygiene & Tropical Medicine and an M.Phil. in epidemiology from the University of Cambridge.